Ireland
--:--IST
Latest
Clinical Trials in France / NCT05877755
Recruiting Not applicable

Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging

NCT05877755 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-04-15
Last updated
2025-04-22

Condition(s) studied

Cardiac Disease

Investigational drug(s) / intervention(s)

Cardiac MRI acquisition

Cardiac MRI acquisition: All patients will have additional images collected during the magnetic resonance imaging (MRI) examination. These are high-resolution multi-contrast cardiac MRI sequences in gradient echo or in balanced steady state free precession with synchronization on the electrocardiogram. The acquisitions last between 1 minute and 10 minutes. This duration depends on the patient's heart rate and breathing rate. The imaging protocol will last approximately 50 minutes. MRI examinations will be performed on a 1.5 Tesla clinical system with specific cardiac imaging coils.

Study summary

Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory disease, and diabetes. Consequently, the fight against CVD has become the main priority of the World Health Organization. In the pursuit of understanding and treating CVD, cardiac magnetic resonance imaging (CMR) has remained the only modality capable of providing a comprehensive assessment of the heart's function and structure without harmful radiation. Unfortunately, current CMR systems remain too slow, too complex, require highly trained specialists and, as such, have presented a barrier to a wider adoption of CMR. The aim of CARDIO-IRM is to unleash the full potential of CMR to transform patient trajectories by introducing a fast, one-click, fully automated, and comprehensive imaging pipeline applicable to diagnosis, prognosis, and therapy selection in cardiology.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Adult patient (over 18 years of age) requiring an MRI scan as part of their care. * Male or female. * Affiliated or beneficiary of a social security scheme * Having given his/her oral no objection after having read the information note Exclusion Criteria: * Patient unable to give oral consent (guardianship, non-French speaker, etc.) * Patient deprived of liberty * Patient who does not meet the specific eligibility criteria for an MRI examination: pregnant women, known pathology that may interfere with acquisition (e.g. Parkinson's disease), absolute or relative contraindication to an MRI examination * Patient participating in a therapeutic interventional trial or in a period of relative exclusion in relation to another protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chu de Bordeaux Pessac France Recruiting

More University Hospital, Bordeaux trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05877755 on ClinicalTrials.gov ↗ ← All trials in France